Kilitch Drugs (India) Limited (KILITCH.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 4.21B |
| Enterprise Value | 4.93B |
| P/E Ratio | 21.27 |
| PEG Ratio | 1.92 |
| Price/Sales Ratio | 2.82 |
| Price/Book Ratio | 2.32 |
| Enterprise/Revenue | 3.12 |
| Enterprise/EBITDA | 16.04 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.13 |
| Operating Margin | 0.14 |
| Return On Assets | 0.07 |
| Return On Equity | 0.13 |
| Revenue | 2.35B |
| Revenue/Share | 68.77 |
| Gross Profit | 914.13M |
| EBITDA | 366M |
| Net Income | 301.66M |
| Diluted EPS | 8.91 |
| Total Cash | 687.39M |
| Total Cash/Share | 20.07 |
| Total Debt | 887.09M |
| Total Debt/Equity | 0.32 |
| Current Ratio | 1.83 |
| Book Value Per Share | 80.86 |
| 52-Week Change | -9.12 |
| 52-Week High | 250 |
| 52-Week Low | 117.25 |
| Moving Average 50 Days | 164.1 |
| Moving Average 200 Days | 168.72 |
| Average Volume | 129,396 |
| Shares Outstanding | 34.96M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | March 24, 2026 |